These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6739149)

  • 1. [Bronchial diffusion of new anti-pseudomonal beta-lactams. Clinical significance].
    Bergogne-Berezin E; Pierre J; Berthelot G; Kafe H; Even P; Gibert C; Safran D; Stern M
    Pathol Biol (Paris); 1984 May; 32(5):421-5. PubMed ID: 6739149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of cefsulodin into bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Safran D; Even P; Kafe H
    Chemotherapy; 1984; 30(4):205-10. PubMed ID: 6744972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ceftazidime absorption into bronchial secretions in mucoviscidosis patients].
    Berthelot G; Lenoir G; Grenier B; Tournier G; Sardet A; Steru D; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):430-4. PubMed ID: 3897974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [penetration of fosfomycin into bronchial secretions].
    Berthelot G; Bergogne-Berezin E; Kafe H; Daumal M; Gillon JC
    Pathol Biol (Paris); 1983 Jun; 31(6):519-21. PubMed ID: 6348660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of ciprofloxacin into bronchial secretions.
    Bergogne-Bérézin E; Berthelot G; Even P; Stern M; Reynaud P
    Eur J Clin Microbiol; 1986 Apr; 5(2):197-200. PubMed ID: 2941280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of the diffusion of cefamandole into bronchial secretions (author's transl)].
    Bergogne-Berezin E; Berthelot G; Even P
    Nouv Presse Med; 1981 Jun; 10(25):2089-91. PubMed ID: 7267304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of antibiotics into respiratory secretions.
    Pennington JE
    Rev Infect Dis; 1981; 3(1):67-73. PubMed ID: 7013001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The penetration of macrolides into bronchial secretions.
    Pierre J; Bergogne-Berezin E; Kafe H; Dournovo P
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():217-20. PubMed ID: 4055550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the diffusion of cefmenoxime into the bronchial secretions.
    Serieys C; Bergogne-Berezin E; Kafe H; Bryskier A
    Chemotherapy; 1986; 32(1):1-6. PubMed ID: 3456295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
    Le Noc P; Robert J; Le Noc D
    Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of ofloxacin into bronchial secretions.
    Symonds J; Bone M; Turner A; Javaid A
    Drugs; 1987; 34 Suppl 1():33-6. PubMed ID: 3481325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of enoxacin into human bronchial mucosa.
    Marlin GE; Braude PD; Whelan AJ; Somogyi AA
    Am Rev Respir Dis; 1986 Dec; 134(6):1209-12. PubMed ID: 3466562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
    Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
    Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penetration of netilmicin into respiratory secretions].
    Bergogne-Berezin E; Berthelot G; Even P; Safran D
    Presse Med; 1983 Feb; 12(5):287-92. PubMed ID: 6220386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Choice of a rapidly bactericidal beta-lactamin-aminoglycoside combination in the treatment of Pseudomonas aeruginosa infections at a child intensive care unit].
    Lambert-Zechovsky N; Bingen E; Guihaire E; Mancy C; Mercier JC; Beaufils F
    Pathol Biol (Paris); 1986 Sep; 34(7):855-8. PubMed ID: 3537930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
    Millar BC; McCaughan J; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Feb; 43(1):92-100. PubMed ID: 29293275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.